Feb 3, 2026· Comment from National Community Pharmacists Association (NCPA)· FDA-2025-N-4731-0040
The National Community Pharmacists Association (NCPA) appreciates the opportunity to provide comments to FDA's request for information (RFI) on increasing access to nonprescription drugs. Please see our full comments attached. NCPA thanks FDA for the opportunity to provide feedback, and we stand ready to work with the agency to offer possible solutions and ideas. Please let us know how we can assist further, and should you have any questions or concerns, please feel free to contact me at steve.postal@ncpa.org or (703) 600-1178.